Company Overview
- Website
- auregen.bio
- Employees
- 18
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Recent News & Media
UK Clinical Laboratory Services Market Size, Growth Outlook 2035
- Apr 29, 2025
- marketresearchfuture.com
On the heels of staff cuts, CRISPR Therapeutics COO departs; Changes galore at Bicycle
- Mar 29, 2025
- endpoints.news
Chutes & Ladders—Yet another exec departs CRISPR Tx
- Mar 28, 2025
- fiercebiotech.com
Up and down the ladder: The latest comings and goings
- Mar 28, 2025
- statnews.com
Auregen Biotherapeutics Announces Appointment of Scott Lauder, Ph.D., as Chief Technology Officer
- Mar 26, 2025
- prnewswire.com
CEO Forum: Lessons from the Frontlines of Medtech Innovation
- Sep 24, 2024
- advamed.org
Who is Auregen BioTherapeutics
Auregen Biotherapeutics is a biotechnology company based in Cambridge, Massachusetts. The company employs 18 people and generates revenue of over $10,000. Auregen Biotherapeutics focuses on the development and commercialization of innovative biotherapeutics. Their products and services are aimed at addressing unmet medical needs in various therapeutic areas. Auregen Biotherapeutics distinguishes itself through its commitment to cutting-edge research and development, leveraging advanced technologies to create novel and effective treatments. For further information or inquiries, please visit Auregen Biotherapeutics' website at auregen.bio.
Company Leadership
Auregen BioTherapeutics Industry Tags
Companies Similar to Auregen BioTherapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Auregen BioTherapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 59 | Boston, MA | ||
| 10M | 27 | Cambridge, MA | 2010 | |
| 10M | 23 | Waltham, MA | 1999 | |
| 10M | 2 | Boston, MA | ||
| 10M | 46 | Woburn, MA |